22 March 2026
: Case report 
Management Strategy for Anaphylaxis in a Patient With Suspected or Confirmed Mastocytosis: A Case Report
Unusual clinical course, Challenging differential diagnosis, Management of emergency care, Rare disease, Educational Purpose (only if useful for a systematic review or synthesis)
Krzysztof Smoluchowski
ABCDEFG 1*, Mateusz Szymański ABCDEFG 1,2, Małgorzata Maria Skiba ABCDEFG 1, Małgorzata Piasecka ABCDEFG 1
DOI: 10.12659/AJCR.951085
Am J Case Rep 2026; 27:e951085
Table 1 Medications used in the treatment of anaphylaxis and the consumption during ICU hospitalization.
| Day 1 of ICU admission (12 hours) | Day 2 of ICU admission (24 hours) | Day 3 of ICU admission (36 hours) | |
|---|---|---|---|
| Epinephrine | 14 mg/12 hAverage dose 0.25 mcg/kg/min | 20 mg/24 hAverage dose 0.18 mcg/kg/min | 0 |
| Dexamethasone | 28 mg | 0 | 0 |
| Hydrocortisonum | 0 | 100 mg | 0 |
| Rupatadine | 20 mg | 30 mg | 20 mg |
| Sodium bicarbonate | 200 mEq | 0 | 0 |
| Clemastine | 2 mg | 0 | 0 |
| Balanced crystalloids | 4500 mL | 1500 mL | 500 mL |